Geriatric Aspects of Primary Endometrial Cancer

The Pros and Cons of Estrogen Administration After the Menopause†

“…Neither have we seen a patient in this latter group who has continued to bleed when treatment has been temporarily discontinued and later reinstituted at a lower individualized dosage level. The question of the so‐called high incidence of uterine malignancy, coexisting with prolonged estrogen elaboration, femininizing ovarian tumors and uterine fibroids, has been most effectively answered by Emge (14). He points out that in a large number of uteri removed by hysterectomy and at autopsy, the coexistence of cancer with such lesions is no greater than that expected by chance.…”